Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.

Extracellular cleavage of the glycoprotein precursor of Rous sarcoma virus.

Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.

Activation of factor XII by tobacco glycoprotein.

Neurotoxicity of macrophages infected by HIV1.

Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Activation and inactivation of neocarzinostatin-induced cleavage of DNA.

A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.

Thrombin-specific inhibition by and slow cleavage of hirulog-1.

Inhibition of cholesterol side-chain cleavage by 22-azacholesterol.

Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.

Carbon-carbon bond cleavage in activation of the prodrug nabumetone.

Choline inhibition of prothrombin activation.

Trypsin action on the growth of Sendai virus in tissue culture cells. IV. Evidence for activation of sendai virus by cleavage of a glycoprotein.

Optimization of irinotecan chronotherapy with P-glycoprotein inhibition.

Inhibition of polyisoprenoid and glycoprotein biosynthesis causes abnormal embryonic development.

PC3.

Transcription of HIV1 is inhibited by DNA methylation.

macrophage infection by HIV1.

P-glycoprotein inhibition of drug resistant cell lines by nanoparticles.

Histidine-rich glycoprotein inhibits contact activation of blood coagulation.

Vaccination with gp160 in HIV.

Suggest Documents

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.

Extracellular cleavage of the glycoprotein precursor of Rous sarcoma virus.

Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.

Activation of factor XII by tobacco glycoprotein.

Neurotoxicity of macrophages infected by HIV1.

Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Activation and inactivation of neocarzinostatin-induced cleavage of DNA.

A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.

Thrombin-specific inhibition by and slow cleavage of hirulog-1.

Inhibition of cholesterol side-chain cleavage by 22-azacholesterol.

Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.

Carbon-carbon bond cleavage in activation of the prodrug nabumetone.

Choline inhibition of prothrombin activation.

Trypsin action on the growth of Sendai virus in tissue culture cells. IV. Evidence for activation of sendai virus by cleavage of a glycoprotein.

Optimization of irinotecan chronotherapy with P-glycoprotein inhibition.

Inhibition of polyisoprenoid and glycoprotein biosynthesis causes abnormal embryonic development.

PC3.

Transcription of HIV1 is inhibited by DNA methylation.

macrophage infection by HIV1.

P-glycoprotein inhibition of drug resistant cell lines by nanoparticles.

Histidine-rich glycoprotein inhibits contact activation of blood coagulation.

Vaccination with gp160 in HIV.

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.

Recommend Documents

Follow Us